Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911179 | Lung Cancer | 2013 | 5 Pages |
Abstract
Neither cancer frequency nor proportion at stage I decreased over 10 years, indicating that screening should not be discontinued. Most cancers were early stage, and overall survival was high. Only a limited number of invasive procedures for benign disease were performed. The Bach model - designed to predict symptomatic cancers - accurately predicted cancer frequency from the third year, suggesting that overdiagnosis is a minor problem in lung cancer screening. The COSMOS model - designed to estimate screening-detected lung cancers - accurately predicted cancer frequency at baseline and second screening round.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
G. Veronesi, P. Maisonneuve, C. Rampinelli, R. Bertolotti, F. Petrella, L. Spaggiari, M. Bellomi,